Архивъ внутренней медицины (Oct 2023)

Neurocognitive Disorders in COVID-19 Patients: Controversed and Unresolved Issues

  • D. P. Kuznetsova,
  • E. V. Efremova,
  • V. V. Gnoevykh

DOI
https://doi.org/10.20514/2226-6704-2023-13-5-344-351
Journal volume & issue
Vol. 13, no. 5
pp. 344 – 351

Abstract

Read online

New Coronavirus Infection (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2). Since 2019, a large number of studies on cognitive impairment in the background of COVID-19 have emerged, and “long COVID” is among them. A non-systematic review based on 2019-2022 studies provides information on the severity of cognitive changes in patients with COVID-19, diagnostic methods that can detect these cognitive impairment and long-term neuropsychiatric and cognitive outcomes that may pose a serious public health challenge.

Keywords